Filing Details

Accession Number:
0001553350-19-000874
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-20 19:48:13
Reporting Period:
2019-08-14
Accepted Time:
2019-08-20 19:48:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1083446 Apollo Medical Holdings Inc. AMEH Services-Management Consulting Services (8742) 870042699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664499 S. Thomas Lam 1668 S. Garfield Avenue
2Nd Floor
Alhambra CA 91801
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-14 7,200 $16.85 1,664,740 No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
Common Stock Acquisiton 2019-08-15 4,000 $15.57 1,668,740 No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
Common Stock Acquisiton 2019-08-15 6,000 $16.19 1,674,740 No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
No 4 P Indirect Held by The Thomas and Jeanette Lam 2002 Family Trust
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $16.63 to $16.92. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
  3. This transaction was executed in multiple trades at prices ranging from $15.55 to $15.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. This transaction was executed in multiple trades at prices ranging from $16.09 to $16.21. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.